The biggest item of the news this weekend is that a Stanford study reports remarkable improvements in people with combat stress and PTSD who were treated with ibogaine. Ibogaine showed even better results than those of MDMA and psilocybin, in several respects: A. It is able to affect several systems in the body at the same time, also in traumatic brain injuries, also in situations of anxiety, also in cognitive functions. B. Unlike MDMA and psilocybin, which require an integrative treatment that incorporates psychotherapy during the treatment itself, the protocol with ibogaine does not include psychotherapy during the experience but only before and after.
Ibogaine has already been included in addiction rehab experiments, and its use may lead to a risk of death following heart rhythm disturbances, and they found that magnesium is able to moderate this phenomenon. Unlike MDMA and psilocybin, which are already in advanced stages of the trial, ibogaine is in the early stages and the researchers face quite a few challenges like the one mentioned in the previous line, before it is approved for treatment.
הצטרפו לרשימת התפוצה שלנו


כתיבת תגובה